114 related articles for article (PubMed ID: 3599595)
1. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
Fujioka T; Tanji S; Koike H; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
Nihon Hinyokika Gakkai Zasshi; 1987 Jan; 78(1):29-38. PubMed ID: 3599595
[No Abstract] [Full Text] [Related]
2. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy].
Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020
[TBL] [Abstract][Full Text] [Related]
3. [Cytotoxic activity of large granular lymphocytes (LGL) infiltrated into metastatic tumors of lung cancer].
Aoyagi Y; Takai K; Shibata A; Ishikawa H; Ohnishi Y
Gan No Rinsho; 1984 Aug; 30(10):1241-6. PubMed ID: 6481960
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
Kaji R; Yoshida H; Yanagawa T; Sato M
J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
[TBL] [Abstract][Full Text] [Related]
5. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
6. [Changes in ASP (antigroup-A streptococcal C polysaccharide antibody) and cardiac and renal effects in cases of urogenital cancers during OK-432 immunotherapy, streptococcus preparation].
Tanji S; Koike H; Kumagai K; Fujioka T; Kubo T; Ohhori T; Yoshida I
Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):49-57. PubMed ID: 3398379
[No Abstract] [Full Text] [Related]
7. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
Umemoto T; Saji S; Oonishi A; Kunii Y; Goshima H; Tachibana S; Takao H; Tanemura H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1512-7. PubMed ID: 3183459
[No Abstract] [Full Text] [Related]
8. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
Kawata H
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
[TBL] [Abstract][Full Text] [Related]
10. [Non-specific immunotherapy with OK-432, streptococcus pyogenes preparation, for inoperable cancer patients of the digestive tract].
Hanaue H; Nomoto S; Yoshizaki S; Kitano Y; Miyakawa S; Horie F; Kurosawa T; Nemoto A; Yasuda H; Takada T
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1307-14. PubMed ID: 6512346
[No Abstract] [Full Text] [Related]
11. [The effect of OK-432 in the treatment of primary lung cancer].
Kishimoto T; Okada K
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1051-6. PubMed ID: 3494430
[TBL] [Abstract][Full Text] [Related]
12. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
13. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
Fujioka T; Shiraishi M; Tanji S; Koike H; Suzuki K; Kumagai K; Aoki H; Sakuma Y; Ohhori T; Kubo T
Hinyokika Kiyo; 1989 Feb; 35(2):253-7. PubMed ID: 2735236
[TBL] [Abstract][Full Text] [Related]
14. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
15. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
[TBL] [Abstract][Full Text] [Related]
16. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
Kim YB
Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
[No Abstract] [Full Text] [Related]
17. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. III. Experimental study using human peripheral neutrophils].
Umemoto T; Saji S; Enami H; Kunii Y; Goshima H; Tachibana S; Takao H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1518-24. PubMed ID: 3183460
[No Abstract] [Full Text] [Related]
19. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
